Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Filament Health announces 4th patent issuance

Stockhouse Editorial
1 Comment| April 28, 2022

{{labelSign}}  Favorites
{{errorMessage}}

Filament Health Corp. (FH) (N.FH, OTCQB: FLHLF, Forum) – a clinical-stage natural psychedelic drug development company – has announced that it has been issued a fourth patent for the extraction and standardization of natural psilocybin and associated psychedelic compounds.

Filament's latest patent was issued by the Canadian Intellectual Property Office (CIPO) and describes essential technology for transforming variable psychedelic raw materials into pharmaceutical-grade, standardized drug candidates.

Ryan Moss, Chief Science Officer at Filament Health, commented:

"Adding a fourth patent to our portfolio demonstrates the calibre of Filament's intellectual property strategy and drug development platform. Our ability to transform valuable natural substances into IP-protected pharmaceutical-grade drug candidates sets us apart as industry leaders."

Fully story here.


New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.


FULL DISCLOSURE: Filament Health Corp. is a client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today